Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Journal of the American Society of Nephrology : JASN|June 10, 2005
Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterolsIsidro B Salusky, William G Goodman, Shobha Sahney, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 17, 2010
Value of the new bone classification system in pediatric renal osteodystrophySevcan A Bakkaloglu, Katherine Wesseling-Perry, Renata C Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccineRobert A Wascher, Donald L Morton, Christine Kuo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysisKatherine Wesseling-Perry, Renata C Pereira, Hejing Wang, et al.
Pediatric Nephrology (Berlin, Germany)|March 21, 2009
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterolsKatherine Wesseling-Perry, G Chris Harkins, He-Jing Wang, et al.
Critical Reviews in Oncogenesis|June 10, 2016
Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We ComeEdward B Garon, Phillip A Abarca, Jennifer L Strunck, et al.
Neurology|May 9, 2014
PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophyMichael D Nelson, Florian Rader, Xiu Tang, et al.
Pageof 8